Tibet AIM Pharm. Inc. (002826.SZ)
CNY 12.02
(-1.8%)
CNY 12.02
(-1.8%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 166.88 Million | 68.45 Million | 109.52 Million | 101.73 Million | 59.2 Million | 13.31 Million |
| Net Income | 15.72 Million | 46.11 Million | 43.47 Million | 41.09 Million | 37.32 Million | 25.25 Million |
| Depreciation & Amortization | 24.13 Million | 22.7 Million | 23.74 Million | 16.74 Million | 10.91 Million | 9.47 Million |
| Deferred income taxes | 1.29 Million | -2.68 Million | 3.55 Million | -3.64 Million | 1.18 Million | 1.14 Million |
| Stock-based compensation | - | 324.89 Thousand | 532.18 Thousand | 1.63 Million | 2.03 Million | - |
| Change in working capital | 111.57 Million | 38.87 Million | 24.78 Million | 37.97 Million | 11.08 Million | -31.75 Million |
| Other non-cash items | 2.95 Million | -36.88 Million | 13.43 Million | 7.93 Million | -3.34 Million | 10.33 Million |
| Investing Cash Flow | -43 Million | -1.71 Million | -53.67 Million | -7.84 Million | -199.37 Million | -63.45 Million |
| Investments in PPE | -3.18 Million | -3.19 Million | -25.19 Million | -38.42 Million | -170.45 Million | -67.71 Million |
| Acquisitions | 79.24 Thousand | 1379.73 | -29.44 Million | 38.46 Million | 170.45 Million | 68.44 Million |
| Investment purchases | -492.14 Million | -200 Million | -240 Million | -90 Million | -415 Million | -365 Million |
| Sales/Maturities of investments | 452.24 Million | 201.48 Million | 240.9 Million | 120.54 Million | 386.08 Million | 368.53 Million |
| Other Investing Activities | -39.82 Million | 0.54 | 56.67 Thousand | -38.42 Million | -170.45 Million | -67.71 Million |
| Financing Cash Flow | -59.3 Million | 27.59 Million | -59.2 Million | -46.78 Million | 39.74 Million | 27.23 Million |
| Debt repayment | -39 Million | -50 Million | -40 Million | -140 Million | -40 Million | -40 Million |
| Dividends payments | -19.06 Million | -19 Million | -15.27 Million | -7.67 Million | -5.69 Million | -12.76 Million |
| Common Stock Repurchased | -22.41 Thousand | -2.64 Million | -3 Million | -7.49 Million | -18.14 Million | - |
| Common Stock Issuance | - | -47.35 Million | 3 Million | 7.49 Million | 18.14 Million | - |
| Other Financing Activities | -22.41 Thousand | 147.35 Million | -3.09 Million | 102.5 Million | 88.14 Million | 39.99 Million |
| Accounts receivables | 170.43 Million | 6.1 Million | 86.18 Million | -44.79 Million | -3.21 Million | -14.2 Million |
| Accounts payables | -46.74 Million | 47.54 Million | -52.43 Million | 77.62 Million | 14.05 Million | -24.19 Million |
| Inventory | -13.41 Million | -12.08 Million | -12.51 Million | 8.77 Million | -939.31 Thousand | 5.5 Million |
| Other working capital | 3.03 Million | -2.68 Million | 3.55 Million | -3.64 Million | 1.18 Million | -37.25 Million |
| Cash at beginning of period | 276.28 Million | 181.97 Million | 185.34 Million | 138.31 Million | 238.7 Million | 261.61 Million |
| Cash at end of period | 340.85 Million | 276.28 Million | 181.97 Million | 185.34 Million | 138.31 Million | 238.7 Million |
| Capital Expenditure | -3.18 Million | -3.19 Million | -25.19 Million | -38.42 Million | -170.45 Million | -67.71 Million |
| Effect of forex changes on cash | -3165.59 | -17.85 Thousand | -18.47 Thousand | -78 Thousand | 32.43 Thousand | 29.06 |
| Net cash flow / Change in cash | 64.57 Million | 94.31 Million | -3.37 Million | 47.02 Million | -100.38 Million | -22.9 Million |
| Free Cash Flow | 163.7 Million | 65.25 Million | 84.32 Million | 63.3 Million | -111.24 Million | -54.4 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 2.17 Million | 11.74 Million | 27.89 Million | -8.5 Million | 15.72 Million | 9.8 Million |
| Depreciation & Amortization | - | 5.49 Million | 5.49 Million | 24.13 Million | 24.13 Million | -11.12 Million |
| Deferred income taxes | - | - | - | - | 1.29 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 220.52 Million | - | 160.06 Million | 111.57 Million | -414.93 Million |
| Other non-cash items | 65.74 Million | -12.84 Million | 25.83 Million | -86.92 Million | 2.95 Million | 416.3 Million |
| Investing Cash Flow | -31.29 Million | 16.47 Million | -154.48 Million | 69.03 Million | -43 Million | 80.39 Million |
| Investments in PPE | -1.29 Million | -3.63 Million | -4.5 Million | -2.03 Million | -3.18 Million | -606.45 Thousand |
| Acquisitions | 2110.00 | 107.6 Thousand | 26.13 Thousand | 65.79 Thousand | 79.24 Thousand | 1050.00 |
| Investment purchases | -80 Million | -130 Million | -150 Million | -79.7 Million | -492.14 Million | -69.86 Million |
| Sales/Maturities of investments | 50 Million | 150 Million | - | 150.71 Million | 452.24 Million | 150.85 Million |
| Other Investing Activities | - | 151.11 Million | -149.97 Million | 71.07 Million | -39.82 Million | -0.12 |
| Financing Cash Flow | -2.83 Million | -31.2 Million | -24.6 Million | 851.13 Thousand | -59.3 Million | -59.19 Million |
| Debt repayment | -2.72 Million | -24.5 Million | -24.5 Million | -1 Million | -39 Million | -40 Million |
| Dividends payments | - | -5.68 Million | -95.29 Thousand | -19.06 Million | -19.06 Million | -19.19 Million |
| Common Stock Repurchased | - | -50.02 Million | -24.5 Million | -22.41 Thousand | -22.41 Thousand | -22.41 Thousand |
| Common Stock Issuance | - | - | - | - | - | 40.02 Million |
| Other Financing Activities | -113.57 Thousand | -5.68 Million | -24.5 Million | 1 Million | -22.41 Thousand | -40 Million |
| Accounts receivables | - | 195.3 Million | - | 170.43 Million | 170.43 Million | -420.36 Million |
| Accounts payables | - | - | - | - | -46.74 Million | - |
| Inventory | - | 25.1 Million | - | -13.41 Million | -13.41 Million | 5.42 Million |
| Other working capital | - | 112.69 Thousand | - | 3.03 Million | 3.03 Million | - |
| Cash at beginning of period | 194.17 Million | 260.48 Million | 385.85 Million | 182.58 Million | 276.28 Million | 161.58 Million |
| Cash at end of period | 227.89 Million | 194.17 Million | 260.48 Million | 340.85 Million | 340.85 Million | 182.58 Million |
| Capital Expenditure | -1.29 Million | -3.63 Million | -4.5 Million | -2.03 Million | -3.18 Million | -606.45 Thousand |
| Effect of forex changes on cash | - | 21.71 Thousand | -29.51 Thousand | -397.05 Thousand | -3165.59 | -234.65 Thousand |
| Net cash flow / Change in cash | 33.71 Million | -66.3 Million | -125.37 Million | 158.26 Million | 64.57 Million | 21 Million |
| Free Cash Flow | 66.62 Million | -10.22 Million | 49.23 Million | 86.73 Million | 163.7 Million | -564.13 Thousand |
JMJFIN
BDULF
VESTUM
FRONTCORP
MRES
PTKFF